1991
DOI: 10.1016/0378-1119(91)90199-l
|View full text |Cite
|
Sign up to set email alerts
|

De novo purine nucleotide biosynthesis: cloning, sequencing and expression of a chicken PurH cDNA encoding 5-aminoimidazole-4-carboxamide-ribonucleotide transformylase-IMP cyclohydrolase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 26 publications
2
21
0
Order By: Relevance
“…The most likely explanation of this result is that enzymes of both pyrimidine and purine biosynthesis are K ϩ iondependent, including carbamoyl phosphate synthetase (the first enzyme of pyrimidine biosynthesis) (19) and AICAR (5-aminoimidazole-4-carboxamide 1-␤-D-ribofuranoside) transformylase-IMP cyclohydrolase, the last enzyme complex of purine biosynthesis (33), which is very likely to require K ϩ ions. This latter conclusion is based on the finding of an essential bound K ϩ ion in the crystal structure of avian AICAR transformylase-IMP cyclohydrolase (9) and the finding that the B. subtilis gene for this enzyme encodes a highly conserved K ϩ ion binding sequence (22). It is notable that all of the pyr and pur mutants obtained here still required K ϩ -ion supplementation for complete surface colonization.…”
Section: Discussionmentioning
confidence: 63%
“…The most likely explanation of this result is that enzymes of both pyrimidine and purine biosynthesis are K ϩ iondependent, including carbamoyl phosphate synthetase (the first enzyme of pyrimidine biosynthesis) (19) and AICAR (5-aminoimidazole-4-carboxamide 1-␤-D-ribofuranoside) transformylase-IMP cyclohydrolase, the last enzyme complex of purine biosynthesis (33), which is very likely to require K ϩ ions. This latter conclusion is based on the finding of an essential bound K ϩ ion in the crystal structure of avian AICAR transformylase-IMP cyclohydrolase (9) and the finding that the B. subtilis gene for this enzyme encodes a highly conserved K ϩ ion binding sequence (22). It is notable that all of the pyr and pur mutants obtained here still required K ϩ -ion supplementation for complete surface colonization.…”
Section: Discussionmentioning
confidence: 63%
“…The strict conservation of these amino acid residues in MTF and the very strong homology in this region among MTF, the glycinamide ribonucleotide formyltransferases, and amino imidazole carboxamide ribonucleotide formyltransferases (46,47) from a number of sources suggest that these amino acids also play a similar catalytic role in MTF. If, as stated above, Lys 207 is at or near the active site of the MTF, it might be close to amino acids 109, 111, and 147 in the three-dimensional structure.…”
Section: Lysmentioning
confidence: 99%
“…The AMPK-activating property of AICAR (via elevation of cellular ZMP) has been used to demonstrate the therapeutic potential for a molecular activator of AMPK, but the short half-life of intravenously administered AICAR, and the resulting rise in levels of blood lactic acid and uric acid, make it unsuitable for direct use as a therapeutic agent (Goodyear, 2008;Karagounis and Hawley, 2009). ZMP is also a cellular metabolite, produced in histidine biosynthesis and de novo purine biosynthesis, but ZMP is only utilized in cells by aminoimidazole carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase (ATIC), a bifunctional 64-kDa enzyme that catalyzes the last two steps of de novo purine biosynthesis (Ni et al, 1991). AMPK activation by exogenous ZMP (administered as the cellpermeable riboside AICAR) suggests a similar function for the endogenous metabolite, indicating the possibility of regulatory crosstalk (via ZMP) between the de novo purine biosynthesis, histidine biosynthesis, and AMPK pathways (Rebora et al, 2005;Corton et al, 1994;Xiao et al, 2007Xiao et al, , 2011.…”
mentioning
confidence: 99%